NOVOSTE CORP /FL/
S-3MEF, 1999-03-16
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Previous: SEALED AIR CORP/DE, 8-K, 1999-03-16
Next: UNITED PAYORS & UNITED PROVIDERS INC, S-8, 1999-03-16



<PAGE>   1
 
     AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON MARCH 16, 1999
 
                                                 REGISTRATION NO. 333-
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
 
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549
                             ---------------------
 
                                    FORM S-3
                             REGISTRATION STATEMENT
                                     UNDER
                           THE SECURITIES ACT OF 1933
                             ---------------------
 
                              NOVOSTE CORPORATION
             (Exact name of Registrant as specified in its charter)
                             ---------------------
 
<TABLE>
<S>                              <C>                              <C>
            FLORIDA                           5047                          59-2787476
(State or other jurisdiction of   (Primary Standard Industrial           (I.R.S. Employer
incorporation or organization)     Classification Code Number)          Identification No.)
</TABLE>
 
                           3890 STEVE REYNOLDS BLVD.
                            NORCROSS, GEORGIA 30093
                                 (770) 717-0904
         (Address, including zip code, and telephone number, including
            area code, of Registrant's principal executive offices)
 
                                THOMAS D. WELDON
                      CHAIRMAN AND CHIEF EXECUTIVE OFFICER
                              NOVOSTE CORPORATION
                           3890 STEVE REYNOLDS BLVD.
                            NORCROSS, GEORGIA 30093
                                 (770) 717-0904
 (Name, address, including zip code, and telephone number, including area code,
                             of agent for service)
                             ---------------------
                                   COPIES TO:
 
<TABLE>
<S>                                                       <C>
               SETH I. TRUWIT, ESQ.                                      PATRICK O'BRIEN, ESQ.
           EPSTEIN BECKER & GREEN, P.C.                                      ROPES & GRAY
                  250 PARK AVENUE                                       ONE INTERNATIONAL PLACE
             NEW YORK, NEW YORK 10177                                 BOSTON, MASSACHUSETTS 02110
                  (212) 351-4500                                            (617) 951-7000
</TABLE>
 
                             ---------------------
    APPROXIMATE DATE OF COMMENCEMENT OF PROPOSED SALE TO PUBLIC: As soon as
practicable after this registration statement becomes effective.
                             ---------------------
    If the only securities being registered on this Form are being offered
pursuant to dividend or interest reinvestment plan, please check the following
box.  [ ]
    If any of the securities being registered on this Form are to be offered on
a delayed or continuous basis pursuant to Rule 415 under the Securities Act of
1933, check the following box.  [ ]
    If this Form is filed to register additional securities for an offering
pursuant to Rule 462(b) under the Securities Act, please check the following box
and list the Securities Act registration statement number of the earlier
effective registration statement for the same offering.  [X]  File No. 333-72073
    If this Form is a post-effective amendment filed pursuant to Rule 462(c)
under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering.  [ ]
                           ---------------
    If delivery of the prospectus is expected to be made pursuant to Rule 434,
please check the following box.  [ ]
                             ---------------------
                        CALCULATION OF REGISTRATION FEE
 
<TABLE>
<CAPTION>
- ------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------
                                               AMOUNT            MAXIMUM              MAXIMUM             AMOUNT OF
           TITLE OF SECURITIES                  BEING        OFFERING PRICE          AGGREGATE          REGISTRATION
             BEING REGISTERED               REGISTERED(1)       PER SHARE         OFFERING PRICE             FEE
- ------------------------------------------------------------------------------------------------------------------------
<S>                                         <C>            <C>                  <C>                  <C>
Common Stock, $.01 par value(2)...........    460,000            $20.00             $9,200,000            $2,557.60
- ------------------------------------------------------------------------------------------------------------------------
- ------------------------------------------------------------------------------------------------------------------------
</TABLE>
 
(1) Includes 60,000 shares that the underwriters have the option to purchase to
    cover over-allotments, if any.
(2) One preferred stock purchase right will attach to and trade with each share
    of common stock sold in the offering. These rights are also covered by this
    registration statement and the value attributable to them, if any is
    reflected in the market price of the common stock.
 
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
<PAGE>   2
 
                                EXPLANATORY NOTE
 
     This Registration Statement is being filed pursuant to Rule 462(b) of the
Securities Act of 1933, as amended (the "Securities Act"), to register an
additional 460,000 shares of Common Stock, comprising the same class of
securities covered by an earlier Registration Statement (File No. 333-72073)
(the "Earlier Registration Statement") filed by Novoste Corporation for the same
offering and declared effective by the Securities and Exchange Commission on
March 15, 1999. This Registration Statement is registering shares in an amount
and at a price that together represent no more than 20 percent of the maximum
aggregate offering price ($54,556,000) set forth in the "Calculation of
Registration Fee" table contained in the Earlier Registration Statement.
 
                           INCORPORATION BY REFERENCE
 
     The information included in the Earlier Registration Statement is hereby
incorporated in this Registration Statement by reference to the Earlier
Registration Statement.
<PAGE>   3
 
                                    PART II
 
                     INFORMATION NOT REQUIRED IN PROSPECTUS
 
ITEM 16.  EXHIBITS
 
     (a) Exhibits:
 
<TABLE>
<CAPTION>
 EXHIBIT
  NUMBER                                     DESCRIPTION
 -------                                     -----------
<C> <C>    <S>  <C>  <C>
 5              --   Opinion by Epstein Becker & Green, P.C., as to legality.(1)
23.1            --   Consent of Ernst & Young LLP (included as page II-3).
23.2            --   Consent of Epstein Becker & Green, P.C. (included in Exhibit
                     5).
</TABLE>
 
- ---------------
 
(1) Filed as same numbered Exhibit to the Registrant's Registration Statement on
    Form S-3 (File No. 333-72073).
 
                                      II-1
<PAGE>   4
 
                                   SIGNATURES
 
     Pursuant to the requirements of the Securities Act of 1933, Registrant
certifies that it has reasonable grounds to believe it meets all of the
requirements for filing on Form S-3 and has duly caused this Registration
Statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Atlanta, State of Georgia, on the 15th day of March,
1999.
 
                                          NOVOSTE CORPORATION
 
                                          By:       /s/ DAVID N. GILL
                                            ------------------------------------
                                                       David N. Gill
                                             Chief Operating Officer and Chief
                                                     Financial Officer
 
     Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed below by the following persons in the
capacities and on the dates indicated.
 
<TABLE>
<CAPTION>
                      SIGNATURE                                     TITLE                    DATE
                      ---------                                     -----                    ----
<C>                                                    <S>                              <C>
 
                          *                            Chairman of the Board, Chief     March 15, 1999
- -----------------------------------------------------  Executive Officer and Director
                  Thomas D. Weldon                     (Principal Executive Officer)
 
                          *                            Director                         March 15, 1999
- -----------------------------------------------------
                 William A. Hawkins
 
                  /s/ DAVID N. GILL                    Chief Financial Officer          March 15, 1999
- -----------------------------------------------------  (Principal Financial and
                    David N. Gill                      Accounting Officer)
 
                                                       Director
- -----------------------------------------------------
              Donald C. Harrison, M.D.
 
                          *                            Director                         March 15, 1999
- -----------------------------------------------------
                  Charles E. Larsen
 
                          *                            Director                         March 15, 1999
- -----------------------------------------------------
                  J. Stephen Holmes
 
                          *                            Director                         March 15, 1999
- -----------------------------------------------------
                 Pieter J. Schiller
 
                          *                            Director                         March 15, 1999
- -----------------------------------------------------
                 Stephen I. Shapiro
 
                          *                            Director                         March 15, 1999
- -----------------------------------------------------
               Norman R. Weldon, Ph.D.
 
                                                       Director
- -----------------------------------------------------
                 William E. Whitmer
 
                 * /s/ DAVID N. GILL
- -----------------------------------------------------
                    David N. Gill
                 as attorney-in-fact
</TABLE>
 
                                      II-2
<PAGE>   5
 
                        CONSENT OF INDEPENDENT AUDITORS
 
     We consent to the reference to our firm under the captions "Selected
Consolidated Financial Data" and "Experts" and to the use of our report dated
February 9, 1999 in the Registration Statement (Form S-3) for the registration
of 460,000 shares of the Common Stock of Novoste Corporation and the related
prospectus.
 
                                          /s/ Ernst & Young LLP
 
                                          ERNST & YOUNG LLP
 
Atlanta, Georgia
March 12, 1999
 
                                      II-3


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission